XML 13 R4.htm IDEA: XBRL DOCUMENT v3.23.3
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended 12 Months Ended
Mar. 15, 2023
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Dec. 31, 2022
Cost of revenue            
Allocated share-based compensation expense   $ 5.8 $ 6.4 $ 17.6 $ 18.8  
Research and development            
Allocated share-based compensation expense [1]   58.6 60.6 178.9 169.6  
Research and development | President            
Allocated share-based compensation expense $ (6.7)         $ 4.4
Sales and marketing            
Allocated share-based compensation expense   5.2 6.0 17.0 16.4  
General and administrative            
Allocated share-based compensation expense   $ 14.2 $ 13.1 $ 41.6 $ 38.6  
[1] On March 15, 2023, the Company's President resigned, resulting in the reversal of $6.7 million in stock-based compensation expense. Of the total amount reversed, $4.4 million related to expense recognized prior to January 1, 2023.